266 related articles for article (PubMed ID: 30129266)
1. Hyponatremia in Cirrhosis: Implications for Liver Transplantation.
Leise M; Cárdenas A
Liver Transpl; 2018 Nov; 24(11):1612-1621. PubMed ID: 30129266
[TBL] [Abstract][Full Text] [Related]
2. Sodium homeostasis during liver transplantation and correlation with outcomes.
Hudcova J; Ruthazer R; Bonney I; Schumann R
Anesth Analg; 2014 Dec; 119(6):1420-8. PubMed ID: 25211389
[TBL] [Abstract][Full Text] [Related]
3. [Hyponatremia in Liver Cirrhosis].
Jang CM; Jung YK
Korean J Gastroenterol; 2018 Aug; 72(2):74-78. PubMed ID: 30145859
[TBL] [Abstract][Full Text] [Related]
4. Influence of preoperative sodium concentration on outcome of patients with hepatitis B virus cirrhosis after liver transplantation.
Wang P; Huang G; Tam N; Wu C; Fu S; Hughes BP; Wu L; He X
Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1210-5. PubMed ID: 27362549
[TBL] [Abstract][Full Text] [Related]
5. Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
Hayashi M; Abe K; Fujita M; Okai K; Takahashi A; Ohira H
Intern Med; 2018 Sep; 57(17):2451-2458. PubMed ID: 29607963
[TBL] [Abstract][Full Text] [Related]
6. Approach and management of dysnatremias in cirrhosis.
Bernardi M; Zaccherini G
Hepatol Int; 2018 Nov; 12(6):487-499. PubMed ID: 30203382
[TBL] [Abstract][Full Text] [Related]
7. Ten pitfalls in the proper management of patients with hyponatremia.
Filippatos TD; Liamis G; Elisaf MS
Postgrad Med; 2016 Jun; 128(5):516-22. PubMed ID: 27153450
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a single-center study.
Crivellin C; Cagnin A; Manara R; Boccagni P; Cillo U; Feltracco P; Barbieri S; Ferrarese A; Germani G; Russo FP; Burra P; Senzolo M
Transplantation; 2015 Jun; 99(6):1257-64. PubMed ID: 25427166
[TBL] [Abstract][Full Text] [Related]
9. Central Pontine Myelinolysis After Living-Donor Liver Transplant: A Report of 2 Cases.
Hsu YL; Hsieh CE; Lin KH; Chou CT; Lin PY; Wang SH; Chen YL
Exp Clin Transplant; 2019 Aug; 17(4):564-567. PubMed ID: 29137593
[TBL] [Abstract][Full Text] [Related]
10. Limited Efficacy of Tolvaptan in Patients with Cirrhosis and Severe Hyponatremia: Real-Life Experience.
Pose E; Solà E; Piano S; Gola E; Graupera I; Guevara M; Cárdenas A; Angeli P; Ginès P
Am J Med; 2017 Mar; 130(3):372-375. PubMed ID: 27746291
[TBL] [Abstract][Full Text] [Related]
11. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
[TBL] [Abstract][Full Text] [Related]
12. Osmotic Demyelination Unrelated to Hyponatremia.
Shah MK; Mandayam S; Adrogué HJ
Am J Kidney Dis; 2018 Mar; 71(3):436-440. PubMed ID: 29277507
[TBL] [Abstract][Full Text] [Related]
13. Hyponatremia in cirrhosis: pathophysiology and management.
John S; Thuluvath PJ
World J Gastroenterol; 2015 Mar; 21(11):3197-205. PubMed ID: 25805925
[TBL] [Abstract][Full Text] [Related]
14. Hypervolemic Hyponatremia (Liver).
Solà E; Ginès P
Front Horm Res; 2019; 52():104-112. PubMed ID: 32097916
[TBL] [Abstract][Full Text] [Related]
15. The Changing Role of Sodium Management in Cirrhosis.
Lizaola B; Bonder A; Tapper EB; Mendez-Bocanegra A; Cardenas A
Curr Treat Options Gastroenterol; 2016 Jun; 14(2):274-84. PubMed ID: 27037930
[TBL] [Abstract][Full Text] [Related]
16. Sodium-reduced continuous venovenous hemodiafiltration (CVVHDF) for the prevention of central pontine myelinolysis (CPM) in hyponatremic patients scheduled for orthotopic liver transplantation.
Lenk MR; Kaspar M
J Clin Anesth; 2012 Aug; 24(5):407-11. PubMed ID: 22658371
[TBL] [Abstract][Full Text] [Related]
17. Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis.
Praharaj DL; Anand AC
J Clin Exp Hepatol; 2022; 12(2):575-594. PubMed ID: 35535075
[TBL] [Abstract][Full Text] [Related]
18. Occult central pontine myelinolysis post liver transplant: A consequence of pre-transplant hyponatremia.
Zhu J; Al-Alkim F; Hussaini T; Vertinsky A; Byrne D; Erb SR; Stoessl AJ; Yoshida EM
Ann Hepatol; 2019; 18(4):651-654. PubMed ID: 31056363
[TBL] [Abstract][Full Text] [Related]
19. Utility of Tolvaptan in the Perioperative Management of Severe Hyponatremia During Liver Transplantation: A Case Report.
Parekh A; Rajaram P; Patel G; Subramanian RM
Transplant Proc; 2017 Dec; 49(10):2399-2401. PubMed ID: 29198689
[TBL] [Abstract][Full Text] [Related]
20. Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation.
Leise MD; Yun BC; Larson JJ; Benson JT; Yang JD; Therneau TM; Rosen CB; Heimbach JK; Biggins SW; Kim WR
Liver Transpl; 2014 Jun; 20(6):687-97. PubMed ID: 24616214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
